Drug profile · INN
lomitapide mesylate
JUXTAPID
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
lomitapide mesylate (JUXTAPID) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN lomitapide mesylate
Brand JUXTAPID
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is lomitapide mesylate?
lomitapide mesylate (JUXTAPID) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for lomitapide mesylate?
JUXTAPID is a marketed brand name for lomitapide mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lomitapide mesylate?
lomitapide mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.